OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells therapy(Changhai Hospital)

N/A

Report date: 2025/08/01 20:01:42

Base Information

Drug NameOCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells therapy(Changhai Hospital)
Drug Alias Namemesenchymal stem cells with OCN-19 therapy(Changhai Hospital)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChanghai Hospital
China Registration ClassN/A

Develop Information

Active CompaniesChanghai Hospital
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A